michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I couldn't get your question. Sorry, jean, could you repeat it please?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. So if you look at our past several years, Chinese New Year seasonality, certainly, the first quarter is the weakest quarter for us, not only for us, actually for the other -- most of the Chinese companies as well. First quarter because that's the Chinese New Year and basically, at least the two weeks, nobody is working, right? So basically, nobody is spending money. So that certainly will impact the demand for JG Alliance business.
For the other business because it's subscription-based, right? So it's a highly, highly stable, highly visible. But that said, overall, for the company as a whole, you should see certain magnitude of seasonality in the first quarter, i.e., there will be sequential revenue decline by a little bit in the first quarter.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
It does, Dave. We've talked about this before. As much as we'd like to deploy the money faster, we also can't tell our folks not to do their jobs on the other end. It's one of the things and one of the reasons we've more than double the size of our treasury team in the last few years, and it's paying dividends for us. And even with that, they come in with new relationships exciting. And the first thing Chris and I think about is how do we lend the money out.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. So if we think about the fourth quarter we gave some -- by the way we gave some data on the second and third quarter. I think we were roughly $5 million benefit in the second quarter on these type of -- COVID-type of enhanced expenses, if you will and then third quarter about $4 million. Fourth quarter will be about a $5 million number. So T&E continues to become -- kind of drop off a little bit as it normalize. We had a little bit bigger number on group health though, again tied to less doctor visits, less elective surgeries, those type of things.
So as we enter '21, we would expect both of those numbers to continue to normalize. From a T&E standpoint, Robert and I and the team are going to do everything we can, obviously, to minimize those number normalizing back to historical levels. Group health is probably not a heck of a lot we can do, but-- because that will come back, but yeah that's baked into our guidance. By the way, while -- just while I bring up the guidance, real quick, I did want to note, we're going to post a slight correction to the 2021 adjusted EBITDA recon, that's the last slide of our earnings release. There's some impact interest expense and taxes, which will be modified and we'll have that out today so.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. The high levels of growth were not just because of easy comps at all. I mean Guy Carpenter's comp was at nine last year. Marsh was a one. So it was not exactly layoffs in terms of comps. I think that we have real momentum right now. And the U.S. economy is getting stronger, JLT integration is well behind us and the combined organization is emerging from the pandemic stronger than what we went in and focused on our front foot. New business generation was terrific across the businesses, and our growth was broad-based. The retention is strong, pricing is a tailwind and we're benefiting from disruption and flight to quality and stability. So there are a lot of factors that are underpinning our revenue growth, and we feel very good about revenue growth into the future.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So as we think about the digital business, as the market matures, customer acquisition is becoming less of a driver in product picks up some of it. You launched your new sportsbook yesterday, the new app. Can you just talk about some of the key features of it?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Mission-critical. For us to truly disrupt personal ownership, we have to democratize shared mobility. And the self-driving and mobility in the driven world are absolutely mission-critical for the company to disrupt ourself. I am really proud of the team's progress.
It's different than our competitors in the space. We've gone to the most difficult miles in four, five different cities. Our mapping, our SDS deployment, and the algorithms are built to be scaled for production deployment. So we're not going to a small market area in easy miles like others.
We're taking on the toughest problems now and building our capability for scaling quickly. And I think that's always been our approach. The relationship with Argo and us and Volkswagen is very close, but we do see us moving into more of a production mode now, and we're really ready for that. And we think this will take more capital and a little more time, and we think the access to public capital is really mission-critical for our journey.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I think, first, let's look at the lay of the land backwards. You had the rupture of the pandemic -- let's go even back, we had a record Q1, you had the rupture of the pandemic, but as we compared to competition, I believe we were stronger quarter in, quarter out over several of the last quarters. So whether it was up or down, the sequential nature of it, remember, we talked about ploughing through our backlog. So with that as a backdrop, as we move through, we should expect some lift in the second and third quarters that we would normally see. I think that's why we highlight the return of the discretionary and small projects, which I think will certainly be better than it was a year ago. The 'but' is that new construction demand is not as robust as it was going into the pandemic. So I think it takes '21 to normalize itself and we'll see probably a truer picture of what the market is going to be and we believe better as we go into '22.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, I think there are two time frames here. In the near term because of the degree of uncertainty about how long vaccination process is going to take whether we're going to get a mutant strain that's resistant to vaccines, I think it's prudent as a lender to be focused on COVID resistant companies, COVID resistant borrowers right now. There are some hedge fund players in distressed debt who disagree with me and are loading up on movie theaters and amusement parks and cruise ships and a variety of similar credits, but that's not what we're doing.
In the longer term, assuming that the vaccines are effective and we get back to something that we can call normal, I think there is an element of underwriting that's going to be forever changed. I don't think I'm ever going to forget what this global pandemic has looked like and the idea of people congregating in close proximity being a risk factor that we need to think about in an underwriting context. I think that's going to be around for a long time.
Does that mean that all such companies are going to be ruled out? Probably not. But does it mean that we're going to need to factor in potential new pandemics as a downside case? I think that would be prudent. So, it's going to be interesting to see how that dynamic plays out, David. I think we're likely to see different players approach your question in different ways.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi. Thank you very much. Congratulations, Bill and Gina and the rest of the team. My question for you, Bill, is the company has done a phenomenal job increasing its wallet share with really large companies through ITSM Pro, system workflow, HR, etc.
My question for you, as you approach the $10 billion journey and you look at other markets and software, you tend to have companies that's in database market or ERP, have a customer base that's closer to 100,000, 200,000, maybe even 400,000, 500,000. So as you look at the -- how do we put the scaling up of ServiceNow into a company that can serve not just 8,000, 9,000 customers, but more like 100,000, 200,000 customers, what does that journey look like? And what are your plans to make this excellent piece of technology that's known to less than 10,000 to be actually known and adopted by 100,000, maybe 200,000 customers. Thank you so much. That's my only question.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, Doug, as we said, there is still an overhang of oil inventory in the world. And we recognize that. And -- but I think that U.S. producers in general have been very disciplined in their approach and watch the market and what the demand is. We still see some curtailed demand due October 19, and everybody is anxious to see, waiting the return of demand back to normal. But I think going forward with activity at [Port Adeline] and, I mean, if you look at [420 rigs] operating in the U.S., we see that supply and demand is coming back into balance and which bodes well for commodity prices in the future.
So obviously, as long as OPEC functions as they do, it had been reasonably in different remains in the industry, we feel very positive about the commodity risk.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. Yeah Pete, I would say that's certainly a part of our production plan. We want to make sure that should we receive an export license and that goes quicker than we think that we're able to support the customer, yeah,

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi. Thanks for taking my questions. I'll start with one follow-up for Steven. On your comments out to -- when you were discussing that you've seen pathway engagements at hepcidin pathway, were you speaking just about iron release or have you seen rises in red blood cell count in that monotherapy trial? And then for Barry, maybe if you can give a little more granularity on what you mean by broad access? I guess, one, have any meaningful contracts been signed yet or at least getting very close to finalization, where maybe you can speak to what type of step edits you're expecting to be in those final agreements?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
At a high level Jeremy, it's hard to make generalizations around these things. But I think what was unusual here was for a variety of reasons, this particular fund wound up with very concentrated positions very quickly, and I think that was unusual. And then the actions that they chose to take, or chose not to take, obviously affected the outcome. But I think it was unusual with respect to the size and the concentration of positions which changed relatively quickly.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I think you were talking about acquisitions, you broke up, but sorry.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, Gary, John and Karen. Hope you're doing well. Just wanted to touch base on John's comments in the opening remarks about how Safe Harbor portfolios doing better than your underwriting. What's driving that? Is it like something on the revenue side, expense side or something else, just curious?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, so let me take those two questions -- two part question there. Our priorities are, we want to continue to make smart investments in the business. We will do that. We've been [Indecipherable] that we continue to maintain our R&D at a pretty high level and we will look to continue to add to our capabilities, as we need -- as we see fit. But we also, I think have been pretty transparent about the fact that we think our shares have been dramatically undervalued and so we have been focused on returning cash to shareholders. We've detailed that over several quarters now. We're upto end -- or coming to an end next week of a accelerated share repurchase program that we put in place in Q4. As we do that we will have used up about two-thirds of the authorization that we just got in last November. But we still have some remaining authorization, close to $100 million of authorization left, and we will continue to monitor our stock price and do that and make incremental decisions from here. But our plan is to -- we're quite comfortable with no net debt as you heard me say, we in fact have net cash position right now. So we have tremendous capacity to continue to return cash to shareholders.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. In terms of Rollic, it will be all of the above, Gerrick. In terms of the core business, what -- and we talked about this on the last earnings, what we're actually seeing with some of the key franchises is that they're actually starting to behave more like sustainable live services as opposed to in and out hyper-casual games. So from that perspective, the team is looking to build sort of iterative sort of events and bold beats into some of the franchises.
But we also have continued to expand the first-party and third-party network of developers that we work with, and we plan to continue to do that into '22. So you will see obviously a strong flow-through of games coming through Rollic like both owned IP developed and obviously, third-party partner games. And ultimately, over time, as we leverage our ad tech platform, we'll be able to drive even stronger flow-through of those bookings into Zynga.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you for taking my questions. Two -- I have maybe two parts of the question regarding transportation. First, just wondering if you can remind us the translocation or chromosomal abnormality rate for the EDIT-101. And then secondly, you do have a few approaches with multiplexing. I know that they will lead to some translocation. So just wondering -- I know you did mention that you do have a very deep sequencing to identify these, so just wondering what is the process in place to monitor translocation? And what would be the cutoff for the drug product in terms of product release?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, thanks. Can you talk about just how the Redpine acquisition is going? And particularly versus your initial expectations, whether it's design funnel and some of the momentum that you're seeing in that business?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. Thanks, David. I appreciate you being an investor also. I don't -- I wouldn't say so because the portfolio as we stand right now, obviously, we're -- as we've just been talking, we really focus a lot on the income coming off of the existing portfolio. It's not unusual, by the way. For us, as you know, our general level of activity is we don't do -- we don't go into a whole bunch of new deals. We're very careful in how we go about doing them. Our underwriting is pretty thoughtful. Really, the key is that when I say tightness, it's tight because there is a lot of money out there in the private equity world and in the buyout business, which is where we compete. So we try to be cautious as we look at new companies.
The good news is that we are seeing, as I mentioned, more activity, meaning more companies that are looking to be sold that we have an opportunity to look at. So I don't see it as really -- as bringing down the income. It's really more a question of how rapidly, so to speak, we can add to our assets and continue to increase the income and thereby obviously slightly increase our monthly dividend payout. So that's really our target, our goal. But it's what we do every day. And I'm not overly optimistic. But I'm certainly encouraged by what I'm seeing on the new deal pipeline front, so to speak.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Sure, Ryan. This is Seth, again. I can take that.
Yes, we view it as incremental. And if you look at where we've rolled out these lives, a lot of it's with some of our national relationships and the larger payers. And what's nice about it is that you can go across the country, state by state very quickly. You don't have to align on what a benchmark is, what you have to do for the performance product, and that takes more time.
So you can kind of get to a place where the math is a lower PMPM, higher margin, but a lot more lives. And then we will see opportunities to come in behind and set up the full performance suite as a follow-on. And the Florida Blue example, which I mentioned a minute ago is an example where that's only 125,000 lives and $75 million of revenue. And so it doesn't take many of that 6.2 million to convert over to make the whole thing work really well.
So we view it as additive and really excited about it.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
No. I think we've definitely seen it in the pipeline, and we've seen it in just the number of reps that are now selling some of the newer products. I think we have a lot of confidence that they've got their sea legs on selling the solution side. And post close of this transaction, I think we're going to be in a really good spot from a capacity and productivity standpoint.

    Prediction (one of UP, DOWN, SAME): DOWN